e-learning
resources
Courses
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Robert Naeije (BRUSSELS, Belgium)
Source:
ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Number:
4
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robert Naeije (BRUSSELS, Belgium). Pathophysiology of pulmonary hypertension: what the interested clinician needs to know. ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Panel discussion on acute decompensated pulmonary hypertension
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how?
Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases
Year: 2020
Assessing risk in pulmonary arterial hypertension: what we know, what we don't
Source: Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017
Year: 2017
Pulmonary hypertension: what can we learn from studies?
Source: International Congress 2015 – Practising personalised medicine: why, when, and how?
Year: 2015
Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005
Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet?
Source: Eur Respir Rev 2014; 23: 458-468
Year: 2014
Update on severe asthma: what we know and what we need
Source: Eur Respir Rev 2009; 18: 58-65
Year: 2009
Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Challenges in pulmonary hypertension: managing the unexpected
Source: Eur Respir Rev 2015; 24: 674-681
Year: 2015
Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
Year: 2021
Pulmonary arterial hypertension among elderly patients: an emerging problem?
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
Pulmonary hypertension: what does the pathology tell us?
Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician
Year: 2010
Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018
What's it like to live with idiopathic pulmonary fibrosis? Ask the experts
Source: Eur Respir J 2016; 47:1324-1326
Year: 2016
Clinical trials in pulmonary arterial hypertension: what do they tell us
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
Clinical trials in pulmonary arterial hypertension: what they tell us
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Clinical trials in pulmonary arterial hypertension: what do they tell us
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing?
Source: Eur Respir J, 54 (2) 1901278; 10.1183/13993003.01278-2019
Year: 2019
Making the diagnosis of acute pulmonary embolism: what do the guidelines say?
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept